Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Post-progression outcomes from the phase 2 IMvigor210 study Meeting Abstract
| Authors: | Necchi, A.; Joseph, R. W.; Loriot, Y.; Hoffman-Censits, J.; Perez Gracia, J. L.; Petrylak, D. P.; Zhu, Q.; Ding, B.; Kaiser, C.; Rosenberg, J. E. |
| Abstract Title: | Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Post-progression outcomes from the phase 2 IMvigor210 study |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx371.007 |
| Language: | English |
| ACCESSION: | WOS:000411324002043 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx371.007 |
| Notes: | Meeting Abstract: 852PD -- Appears on pages 298-299 of the abstract book -- Source: Wos |
